The UK will remain a world-class place for life sciences, regardless of Brexit – but overseas companies can benefit from experienced guides on how to set up and thrive here, say Mark Edwards an
GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.